English
Investors
Shareholders
EQT logo
About
Teams
Sustainability
Investments
Media
Important notice
Current portfolio
AM-Pharma
Dutch clinical stage biopharmaceutical company developing a treatment for acute kidney injury.
Sector
Healthcare
Country
Netherlands
Fund
LSP 6
Entry
2019
Web
am-pharma.com
Sector
Healthcare
Country
Netherlands
Fund
LSP 6
Entry
2019
Web
am-pharma.com
0
Investments
EQT logo